| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/26/2002 | US20020137778 Anticancer, antiarthritic, and antiinflammatory agents |
| 09/26/2002 | US20020137775 Novel delta dicarbonyl compounds and methods for using the same |
| 09/26/2002 | US20020137755 Tyrosine kinase inhibitors |
| 09/26/2002 | US20020137715 Blocking Sp1 transcription factor broadly inhibits extracellular matrix gene expression in vitro and in vivo: implications for the treatment of tissue fibrosis |
| 09/26/2002 | US20020137693 Comprising an admixture of a natural inhibitor of epidermal growth factor receptor (EGFR) activation or a derivative or analog and a dermatological carrier; antipeeling agents; genistein and other isoflavones and other plant extracts |
| 09/26/2002 | US20020137691 Supplement collagen and elastic tissues and thicken the dermis; administering a sugar compound converting mucopoly-saccharides; enzyme inhibitor of collangenase/elastase; an amino acid; fat burner, vaso-dilator and chromium picolinate |
| 09/26/2002 | US20020137687 Novel compounds that inhibit tryptase activity |
| 09/26/2002 | US20020137676 Selective treatment of endothelial somatostatin receptors |
| 09/26/2002 | US20020137086 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylation status of the genes |
| 09/26/2002 | US20020136787 Method of treating prickly heat |
| 09/26/2002 | US20020136753 Oolong tea extract; antiinflammatories, anti-atopic dermatitis agent or antipsoriatic agent |
| 09/26/2002 | US20020136726 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 09/26/2002 | US20020136699 Rinsed or nonrinsed products particularly for hair washing, hair care, hair conditioning, hair dressing or hair setting. |
| 09/26/2002 | DE10114561A1 Creatine, creatinine and/or their salts or derivatives are used in agents for repairing hair or increasing its gloss, volume or combability |
| 09/26/2002 | DE10114305A1 Reducing sebum production using cosmetic or dermatological preparations containing isoflavones, useful for e.g. eliminating comedones or treating greasy hair or dandruff |
| 09/26/2002 | DE10112771A1 New 3-acylamino-3-phenyl-propionic acid derivatives, are integrin inhibitors useful e.g. for treating thrombosis, cardiac infarction, angina pectoris, tumor diseases, inflammation, osteoporosis or infections |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/26/2002 | CA2444526A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2441510A1 Muteins of hypoxia inducible factor alpha and methods of use thereof |
| 09/26/2002 | CA2441503A1 Method for cleaving human growth hormone gh |
| 09/26/2002 | CA2441425A1 Antipruritics |
| 09/26/2002 | CA2441152A1 Hormone replacement therapy |
| 09/26/2002 | CA2441111A1 Method for targeting chemical compounds to cells and pharmaceutical compositions used therein |
| 09/26/2002 | CA2440687A1 Dermatological preparations |
| 09/26/2002 | CA2440632A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440631A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440482A1 Tryptase-inhibitors |
| 09/26/2002 | CA2440480A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions |
| 09/26/2002 | CA2440475A1 Metalloproteinase inhibitors |
| 09/26/2002 | CA2440272A1 Nucleic acid-associated proteins |
| 09/26/2002 | CA2440264A1 Triazaspiro[5.5]undecane derivative and pharmaceutical composition comprising the same as active ingredient |
| 09/26/2002 | CA2439916A1 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/26/2002 | CA2439757A1 Methods of using neural thread proteins to treat tumors and other conditions requiring the removal or destruction of cells |
| 09/26/2002 | CA2439530A1 Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases |
| 09/26/2002 | CA2436911A1 Pyrazolo`4,3-d.pyrimidinone compounds as cgmp pde inhibitors |
| 09/25/2002 | EP1243589A1 Heteroaryl-substituted pyrrole derivates, their preparation and their therapeutic uses |
| 09/25/2002 | EP1243581A1 Pyridinium compounds useful for the treatment of AGE-related diseases |
| 09/25/2002 | EP1243274A2 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract |
| 09/25/2002 | EP1243252A1 Skin composition containing fibres and ubiquinones |
| 09/25/2002 | EP1242596A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
| 09/25/2002 | EP1242590A2 Human lyases and associated proteins |
| 09/25/2002 | EP1242455A1 N-alkylated peptides having antiangiogenic activity |
| 09/25/2002 | EP1242451A2 Compositions and methods for inhibiting endothelial cell proliferation |
| 09/25/2002 | EP1242437A2 Novel stromelysin inhibitors |
| 09/25/2002 | EP1242422A1 Tricyclic dihydropyrimidine potassium channel openers |
| 09/25/2002 | EP1242417A1 Oxazolidinones having a sulfoximine functionality and their use as antimicrobial agents |
| 09/25/2002 | EP1242415A1 3-thiazol-4-yl-pyrrolidine derivatives as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242407A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242404A1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 09/25/2002 | EP1242403A1 2,4-diaminopyrimidine compounds usful as immunosuppressants |
| 09/25/2002 | EP1242400A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242398A2 Partially saturated calcium channel blockers |
| 09/25/2002 | EP1242396A1 New p2x 7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 09/25/2002 | EP1242395A1 Benzoic acid esters of oxazolidinones having a hydroxyacetylpiperazine substituent |
| 09/25/2002 | EP1242385A1 Cytokine, especially tnf-alpha, inhibitors |
| 09/25/2002 | EP1242382A1 Tricyclic protein kinase inhibitors |
| 09/25/2002 | EP1242371A1 Hydrazone and oxime derivatives of pyrrolidine as amp-specific phosphodiesterase inhibitors |
| 09/25/2002 | EP1242364A1 Adamantane derivatives |
| 09/25/2002 | EP1242352A2 Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states |
| 09/25/2002 | EP1242120A2 Combinations of growth factors and i:upa or i:mmp for the treatment of damaged tissue |
| 09/25/2002 | EP1242118A1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists |
| 09/25/2002 | EP1242114A2 Use of enzymes for skin expansion |
| 09/25/2002 | EP1242104A2 Process of obtaining thylakoids from plants, pure thylakoids and use thereof |
| 09/25/2002 | EP1242103A1 Extracts derived from pueraria mirifica, butea superba and/or mucuna collettii and extraction thereof |
| 09/25/2002 | EP1242102A2 Asthma/allergy therapy that targets t-lymphocytes and/or eosinophils |
| 09/25/2002 | EP1242100A2 Regenerative adjuvant |
| 09/25/2002 | EP1242097A2 Pharmaceutical composition comprising a vanadium compound and at least a component selected from a na+/h+ exchanger, cyclo-oxygenase inhibitors and caspase inhibitors |
| 09/25/2002 | EP1242045A2 Use of an extract of at least one vaccinium-type plant as an anti-glycation agent |
| 09/25/2002 | EP1159000B1 Preparation for the treatment of pigmentation disorders |
| 09/25/2002 | EP1100456B1 Use of ectoine or ectoine derivatives in formulations |
| 09/25/2002 | EP1070059B1 Chromanone and thiochromanone derivatives |
| 09/25/2002 | EP1069884B1 Cosmetic or pharmaceutical agents containing ribonucleic or desoxyribonucleic acids |
| 09/25/2002 | EP0912184B1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 09/25/2002 | EP0753297B1 Lotion |
| 09/25/2002 | EP0702551B1 Compositions and methods for reparation and prevention of fibrotic lesions |
| 09/25/2002 | CN1371359A Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/25/2002 | CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia |
| 09/25/2002 | CN1371285A Methods and compounds for treatment of immunologically-mediated diseases using mycobacterium vaccae |
| 09/25/2002 | CN1371282A Medicaments that contain xenogenic oligo-or/and polyribonucleotides |
| 09/25/2002 | CN1371272A Cosmetic composition containing pantothenic acid |
| 09/25/2002 | CN1370588A Aloe gelatin |
| 09/25/2002 | CN1370584A Skin-moisturizing ointment for treating burns |
| 09/25/2002 | CN1370577A Kangfushuang cream for treating allergic dermatitis, eczama and other skin inflammations |
| 09/25/2002 | CN1370574A Antiphlogistic bolus made of honeysuckle, antelope horn and gentian |
| 09/25/2002 | CN1370570A Medicine compoistion for traeting burns and scalds |
| 09/25/2002 | CN1370569A Composite Chinese medicine powder for treating burns and scalds |
| 09/25/2002 | CN1370566A Compounding process of dermatosis treating medicine |
| 09/25/2002 | CN1370548A Rongbanxiao medicine for eliminating facial spot and its prepn |
| 09/25/2002 | CN1370535A Method of inhibiting skin damage of vitamin A analog |
| 09/25/2002 | CN1370526A Treating method of nuclear factor-KB mediated diseases and dysfuction |
| 09/25/2002 | CN1370520A Spot eliminating ointment |
| 09/25/2002 | CN1370518A Biological anti-senility cosmetics |
| 09/25/2002 | CN1370459A Hair restoring and blackbening health beverage |
| 09/25/2002 | CN1091383C Process for powdered medicine from natural plant medicated bath liquid |
| 09/25/2002 | CN1091374C External medicine for treating sore caused by shell wound or bullet wound |
| 09/25/2002 | CN1091373C Use of calomelas in pharmacy |
| 09/25/2002 | CN1091371C Skin nursing cream for curing comedo |
| 09/24/2002 | US6455592 Use of hydrophilic penetration agents in dermatological compositions for the treatment of onychomycoses, and corresponding compositions |
| 09/24/2002 | US6455582 Treating cancer |
| 09/24/2002 | US6455572 Estrogen agonist/antagonist metabolites |